HTA Programme researcher-led evidence synthesis

The NIHR Health Technology Assessment (HTA) Programme is looking to fund evidence synthesis research. In this researcher-led workstream, we are interested in receiving proposals addressing any health problem in areas not otherwise well covered in our HTA portfolio.

This is a two-stage, researcher-led funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.

You should demonstrate knowledge of current research in the field and of evidence synthesis methods and state how these would apply to the question posed. Valid and reliable methods should be proposed for identifying and selecting relevant material, assessing its quality and synthesising the results. Find guidance on choice of appropriate methods contained in NHS CRD Report Systematic Reviews: CRD’s guidance for undertaking reviews in health care (third edition).

Please note that proposals should be within the scope of the HTA Programme.

Eligibility

See our HTA Programme page for details about the overall programme remit and eligibility criteria.

Brain tumours highlight notice

This highlight notice indicates our continuing interest in receiving research proposals in this area, and encourages collaborative applications that demonstrate how they build on recent initiatives and investment in the area made by the NIHR, the Medical Research Council (MRC) and other research funders.

For further details, please see the themed funding opportunity pages.

Studies within a trial or review

This funding opportunity is eligible for a SWAT/SWAR (study within a trial or study within a review), which can help significantly improve methodology of future research as well as the host study. Find out about the benefits of SWATs/SWARs and how to include one in your application.